Division of Health Chemistry, Department of Healthcare and Regulatory Sciences, School of Pharmacy, Showa University.
Division of Bioanalytical Chemistry, Department of Pharmaceutical Sciences, School of Pharmacy, Showa University.
Biol Pharm Bull. 2019;42(5):850-855. doi: 10.1248/bpb.b19-00085.
Acyl-CoA synthetase long-chain family members (ACSLs) are a family of enzymes that convert long-chain free fatty acids into their acyl-CoAs. ACSL4 is an ACSL isozyme with a strong preference for arachidonic acid (AA) and has been hypothesized to modulate the metabolic fates of AA. There are two ACSL4 splice variants: ACSL4V1, which is the more abundant transcript, and ACSL4V2, which is believed to be restricted to the brain. In the present study, we expressed recombinant human ACSL4V1 and V2 in Spodoptera frugiperda 9 (Sf9) cells using the baculovirus expression system and then partially purified both variants by cobalt affinity column chromatography. We then established a novel ACSL assay system with LC-MS/MS, which is highly sensitive and applicable to various kinds of fatty acids, and used it to investigate the substrate specificity of recombinant human ACSL4V1 and V2. The results showed that both ACSL4 variants preferred various kinds of highly unsaturated fatty acids (HUFAs), including docosahexaenoic acid (DHA), adrenic acid (docosatetraenoic acid) and eicosapentaenoic acid (EPA), as well as AA as a substrate. Moreover, our kinetic studies revealed that the two variants had similar relative affinities for AA, EPA and DHA but different reaction rates for each HUFA. These results confirmed the importance of both of ACSL4 variants in the maintenance of membrane phospholipids bearing HUFAs. Structural analysis of these variants might reveal the molecular mechanism by which they maintain membrane phospholipids bearing HUFAs.
酰基辅酶 A 合成酶长链家族成员 (ACSLs) 是一类将长链游离脂肪酸转化为酰基辅酶 A 的酶。ACSL4 是一种 ACSL 同工酶,对花生四烯酸 (AA) 有很强的偏好,并且被假设可以调节 AA 的代谢命运。有两种 ACSL4 剪接变体:ACSL4V1,其丰度更高,而 ACSL4V2 则被认为仅限于大脑。在本研究中,我们使用杆状病毒表达系统在 Spodoptera frugiperda 9 (Sf9) 细胞中表达重组人 ACSL4V1 和 V2,然后通过钴亲和柱层析部分纯化这两种变体。然后,我们建立了一种新的 ACSL 测定系统,该系统采用 LC-MS/MS,具有高灵敏度,适用于各种脂肪酸,并使用该系统研究了重组人 ACSL4V1 和 V2 的底物特异性。结果表明,两种 ACSL4 变体均优先选择各种高度不饱和脂肪酸 (HUFAs),包括二十二碳六烯酸 (DHA)、二十二碳四烯酸 (adrenic acid) 和二十碳五烯酸 (EPA),以及 AA 作为底物。此外,我们的动力学研究表明,两种变体对 AA、EPA 和 DHA 的相对亲和力相似,但对每种 HUFAs 的反应速率不同。这些结果证实了 ACSL4 变体在维持富含 HUFAs 的膜磷脂中的重要性。对这些变体的结构分析可能揭示它们维持富含 HUFAs 的膜磷脂的分子机制。